Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 6 661-669, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group

TE Moon, N Levine, B Cartmel, J Bangert, S Rodney, M Schreiber, YM Peng, C Ritenbaugh, F Meyskens and D Alberts
Department of Biomathematics, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

The retinoid skin cancer prevention (SKICAP) trials are a set of double-blind, randomized, placebo-controlled clinical trials. The SKICAP-actinic keratoses (AK) trial tests the hypothesis that daily supplementation of retinol (25,000 IU) for 5 years reduces the incidence of skin cancers in high-risk individuals, those with a history of greater than ten clinically or pathologically diagnosed AK and, at most, one prior pathologically confirmed cutaneous squamous cell carcinoma (SCC) or basal cell carcinoma (BCC). The SKICAP-SCC/BCC (S/B) trial tests the hypothesis that daily supplementation of retinol (25,000 IU) or 13-cis-retinoic acid (5 or 10 mg) for 3 years reduces skin cancer incidence in very high-risk individuals, those with a history of at least four pathologically confirmed SCCs or BCCs. Between 1984 and 1988, 2800 participants were enrolled at two clinics on the SKICAP-AK trial; and between 1985 and 1990, a total of 719 participants were enrolled at four clinics on the SKICAP-S/B trial. The initial recruitment strategy was referral by dermatologists, but low accrual necessitated the use of other strategies to achieve enrollment goals, which included involving additional clinics and using paid trial-specific advertisements in print and electronic media. Thirteen % of the SKICAP-AK participants and 36% of the SKICAP-S/B participants were enrolled through dermatologist referral, whereas paid advertisements resulted in enrollment of 87% of SKICAP-AK and 43% of SKICAP-S/B participants. A population-based skin cancer registry was used to identify and enroll the remaining 21% of the SKICAP-S/B participants.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				P. R. Taylor and P. Greenwald Nutritional Interventions in Cancer Prevention J. Clin. Oncol., January 10, 2005; 23(2): 333 - 345. [Abstract] [Full Text] [PDF]

				Managing solar keratoses DTB, May 1, 2002; 40(5): 33 - 35. [Abstract] [Full Text] [PDF]

				J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346. [Abstract] [Full Text] [PDF]

				J. A. Foote, A. R. Giuliano, and R. B. Harris Older Adults Need Guidance to Meet Nutritional Recommendations J. Am. Coll. Nutr., October 1, 2000; 19(5): 628 - 640. [Abstract] [Full Text] [PDF]

				B. Cartmel, T. E. Moon, N. Levine, S. Rodney, and D. Alberts Predictors of Inactivation and Reasons for Participant Inactivation during a Skin Cancer Chemoprevention Study Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 999 - 1002. [Abstract] [Full Text]

				B. Cartmel, T. E Moon, and N. Levine Effects of long-term intake of retinol on selected clinical and laboratory indexes Am. J. Clinical Nutrition, May 1, 1999; 69(5): 937 - 943. [Abstract] [Full Text] [PDF]